571![Office of Combination Products - Endo-CHX Root Canal Cleanser Office of Combination Products - Endo-CHX Root Canal Cleanser](https://www.pdfsearch.io/img/a4665e8b737422354af860fff152f863.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
572![. 4 DEPARTMENT OF HEALTH & HUMAN SERVICES Office of Combination Products . 4 DEPARTMENT OF HEALTH & HUMAN SERVICES Office of Combination Products](https://www.pdfsearch.io/img/20b834a9613fa11ba196d07eb60fe660.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
573![-----------------------CONTRAINDICATIONS------------------------ HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Diovan HCT safely and effectively. See full prescr -----------------------CONTRAINDICATIONS------------------------ HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Diovan HCT safely and effectively. See full prescr](https://www.pdfsearch.io/img/30899c2601d0342663e3d1179106c3ea.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2012-01-23 13:06:56
|
---|
574![-----------------------CONTRAINDICATIONS------------------------ HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Diovan HCT safely and effectively. See full prescr -----------------------CONTRAINDICATIONS------------------------ HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Diovan HCT safely and effectively. See full prescr](https://www.pdfsearch.io/img/ec9e927886bfd6ce36e2251dfe1bea46.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2012-02-17 16:53:43
|
---|
575![CrCl is below 60 mL/min. If a decrease in CrCl is observed in uninfected individuals while using TRUVADA for PrEP, evaluate potential causes and re-assess potential risks and benefits of continued use[removed]HIGHLIGHTS CrCl is below 60 mL/min. If a decrease in CrCl is observed in uninfected individuals while using TRUVADA for PrEP, evaluate potential causes and re-assess potential risks and benefits of continued use[removed]HIGHLIGHTS](https://www.pdfsearch.io/img/14939df4c45057dd222ac8c5be3c395b.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2013-11-05 15:14:26
|
---|
576![The following is a list of the most commonly prescribed drugs. It represents an abbreviated version of the drug list (formulary) that is at the core of your prescription-drug benefit plan. The list is not all-inclusive a The following is a list of the most commonly prescribed drugs. It represents an abbreviated version of the drug list (formulary) that is at the core of your prescription-drug benefit plan. The list is not all-inclusive a](https://www.pdfsearch.io/img/0cb426748d267d801655b283a4f806e7.jpg) | Add to Reading ListSource URL: pbic.nysdoh.suny.eduLanguage: English - Date: 2014-02-24 13:10:21
|
---|
577![U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may](https://www.pdfsearch.io/img/c2b6350865ee8c67f7b8c81624dd18fc.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
578![The following is a list of the most commonly prescribed drugs. It represents an abbreviated version of the drug list (formulary) that is at the core of your prescription-drug benefit plan. The list is not all-inclusive a The following is a list of the most commonly prescribed drugs. It represents an abbreviated version of the drug list (formulary) that is at the core of your prescription-drug benefit plan. The list is not all-inclusive a](https://www.pdfsearch.io/img/b31edf352473894cbb0d4cad135da3e1.jpg) | Add to Reading ListSource URL: www.emblemhealth.comLanguage: English - Date: 2014-07-15 16:19:36
|
---|
579![21 VPD Surveillance Manual, 5th Edition, 2011 Surveillance for Adverse Events Following Immunization: Chapter[removed]Chapter 21: Surveillance for Adverse 21 VPD Surveillance Manual, 5th Edition, 2011 Surveillance for Adverse Events Following Immunization: Chapter[removed]Chapter 21: Surveillance for Adverse](https://www.pdfsearch.io/img/05b0ab4c67e23c8ff49c57c65f3c92be.jpg) | Add to Reading ListSource URL: www.cdc.govLanguage: English - Date: 2011-10-04 13:25:09
|
---|
580![AIDS InfoNet www.aidsinfonet.org Fact Sheet Number 421 AIDS InfoNet www.aidsinfonet.org Fact Sheet Number 421](https://www.pdfsearch.io/img/e1f5f7c8293bd7b633d1233b573650d6.jpg) | Add to Reading ListSource URL: www.aidsinfonet.orgLanguage: English - Date: 2013-09-05 09:55:54
|
---|